HB
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Prevalence and factors associated with severe fatigue 2 years into the COVID-19 pandemic : a cross-sectional population-based study in Geneva, Switzerland | BMJ open |  | 2025 | 93 | 118 | ||
| Covid-19 pandemic-related changes in teleworking, emotional exhaustion, and occupational burnout : a cross-sectional analysis of a cohort study | BMC public health | | 2025 | 76 | 216 | ||
| Association between SARS-CoV-2 infection and anti-apolipoprotein A-1 antibody in children | Frontiers in immunology | | 2025 | 52 | 67 | ||
| Acne-Related Quality of Life and Mental Health Among Adolescents : A Cross-Sectional Analysis | Clinical and experimental dermatology | | 2024 | 100 | 319 | ||
| Biopsychosocial risk factors for subjective cognitive decline among older adults during the COVID-19 pandemic : a population-based study | Public health | | 2024 | 5 | 41 | ||
| Mental health trajectories among the general population and higher-risk groups following the COVID-19 pandemic in Switzerland, 2021-2023 | Journal of affective disorders | | 2024 | 6 | 64 | ||
| Psychosocial factors mediate social inequalities in health-related quality of life among children and adolescents | BMC public health | | 2024 | 6 | 28 | ||
| Patient-Perceived Impact of the COVID-19 Pandemic on Medication Adherence and Access to Care for Long-Term Diseases : A Cross-Sectional Online Survey | COVID | | 2024 | 92 | 95 | ||
| Future time perspectives and concerns among adolescents in 2022 | BMJ paediatrics open | | 2024 | 4 | 16 | ||
| Prevalence of and risk factors for suicidal ideation in adolescents during the COVID-19 pandemic : a cross-sectional study | Swiss medical weekly | | 2024 | 7 | 16 | ||
| Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health—a cross-sectional study | Child and adolescent psychiatry and mental health | | 2023 | 178 | 170 | ||
| Changes in socioeconomic resources and mental health after the second COVID-19 wave (2020–2021) : a longitudinal study in Switzerland | International journal for equity in health | | 2023 | 125 | 125 | ||
| Socioeconomic conditions and children's mental health and quality of life during the COVID-19 pandemic : An intersectional analysis | SSM, population health | | 2023 | 155 | 109 | ||
| Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA.2 wave in Geneva, Switzerland: a population-based study | The Lancet regional health. Europe | | 2023 | 175 | 167 | ||
| Seroprevalence trends of anti-SARS-CoV-2 antibodies and associated risk factors: a population-based study | Infection | | 2023 | 104 | 105 | ||
| Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA.1/BA.2 infection | Nature communications | | 2023 | 146 | 68 | ||
| Development of hybrid immunity during a period of high incidence of Omicron infections | International journal of epidemiology | | 2023 | 88 | 128 | ||
| Specchio-COVID19 cohort study: a longitudinal follow-up of SARS-CoV-2 serosurvey participants in the canton of Geneva, Switzerland | BMJ open | | 2022 | 232 | 85 | ||
| Determinants of adolescents' Health-Related Quality of Life and psychological distress during the COVID-19 pandemic | PloS one | | 2022 | 170 | 179 | ||
| Persistent symptoms after SARS-CoV-2 infection in children: a cross-sectional population-based serological study | BMJ open | | 2022 | 118 | 88 | ||
| A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents | Nature communications | | 2022 | 217 | 106 | ||
| COVID-19-related school disruptions and well-being of children and adolescents in Geneva | Journal of paediatrics and child health | | 2022 | 156 | 133 | ||
| Forgoing healthcare during the COVID-19 pandemic in Geneva, Switzerland – A cross-sectional population-based study | Preventive medicine | | 2022 | 218 | 245 | ||
| Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021 | Euro surveillance | | 2021 | 263 | 147 | ||
| Insights into household transmission of SARS-CoV-2 from a population-based serological survey | Nature Communications | | 2021 | 438 | 224 | ||
| Large variation in anti-SARS-CoV-2 antibody prevalence among essential workers in Geneva, Switzerland | Nature Communications | | 2021 | 260 | 157 | ||
| Association between SARS-CoV-2 Seroprevalence in Nursing Home Staff and Resident COVID-19 Cases and Mortality: A Cross-Sectional Study | Viruses | | 2021 | 277 | 109 | ||
| Seroprevalence of anti-SARS-CoV-2 antibodies after the second pandemic peak | The Lancet Infectious Diseases | | 2021 | 310 | 204 | ||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study | Scandinavian journal of public health | | 2021 | 353 | 159 | ||
| Perceptions of vaccination certificates among the general population in Geneva, Switzerland | Swiss medical weekly | | 2021 | 103 | 119 | ||
| Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study | The Lancet |  | 2020 | 779 | 14 | ||
| Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland | International Journal of Public Health | | 2020 | 300 | 119 | ||
| A twelve-year study of the prevalence, risk factors and characteristics of interval colorectal cancers after negative colonoscopy | Clinics and research in hepatology and gastroenterology | | 2020 | 115 | 97 | ||
| La pharmacie clinique en milieu hospitalier : une enquête de satisfaction auprès des prescripteurs | Annales pharmaceutiques françaises | | 2017 | 78 | 0 | ||
| Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies | BMJ | | 2005 | 179 | 0 | ||
| Exposition domestique au radon et risque de cancer du poumon: Les résultats d’une étude épidémiologique menée en France | Revue des maladies respiratoires | | 2005 | 62 | 0 | ||
| Indoor radon and lung cancer in France | Epidemiology | | 2004 | 76 | 0 | ||
| Seasonal correction factors for estimating radon exposure in dwellings in France | Radiation protection dosimetry | | 2003 | 69 | 0 |
